Butterfly Network Inc

NYSE:BFLY USA Medical Devices
Market Cap
$965.77 Million
Market Cap Rank
#8389 Global
#4241 in USA
Share Price
$4.27
Change (1 day)
+9.21%
52-Week Range
$1.33 - $4.95
All Time High
$27.14
About

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly i… Read more

Butterfly Network Inc (BFLY) - Net Assets

Latest net assets as of September 2025: $203.83 Million USD

Based on the latest financial reports, Butterfly Network Inc (BFLY) has net assets worth $203.83 Million USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($290.00 Million) and total liabilities ($86.17 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $203.83 Million
% of Total Assets 70.29%
Annual Growth Rate -5.83%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 28.59

Butterfly Network Inc - Net Assets Trend (2018–2024)

This chart illustrates how Butterfly Network Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Butterfly Network Inc (2018–2024)

The table below shows the annual net assets of Butterfly Network Inc from 2018 to 2024.

Year Net Assets Change
2024-12-31 $168.83 Million -23.28%
2023-12-31 $220.05 Million -32.37%
2022-12-31 $325.36 Million -27.32%
2021-12-31 $447.69 Million +45139.34%
2020-12-31 $-994.00K -100.66%
2019-12-31 $149.81 Million -38.12%
2018-12-31 $242.10 Million --

Equity Component Analysis

This analysis shows how different components contribute to Butterfly Network Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 66976600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $22.00K 0.01%
Other Components $970.94 Million 575.09%
Total Equity $168.83 Million 100.00%

Butterfly Network Inc Competitors by Market Cap

The table below lists competitors of Butterfly Network Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Butterfly Network Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 220,053,000 to 168,832,000, a change of -51,221,000 (-23.3%).
  • Net loss of 72,492,000 reduced equity.
  • Other factors increased equity by 21,271,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-72.49 Million -42.94%
Other Changes $21.27 Million +12.6%
Total Change $- -23.28%

Book Value vs Market Value Analysis

This analysis compares Butterfly Network Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 5.35x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 0.09x to 5.35x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2018-12-31 $45.93 $4.27 x
2019-12-31 $24.55 $4.27 x
2020-12-31 $-0.16 $4.27 x
2021-12-31 $2.58 $4.27 x
2022-12-31 $1.63 $4.27 x
2023-12-31 $1.07 $4.27 x
2024-12-31 $0.80 $4.27 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Butterfly Network Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -42.94%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -88.34%
  • • Asset Turnover: 0.32x
  • • Equity Multiplier: 1.52x
  • Recent ROE (-42.94%) is below the historical average (-35.82%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2018 -20.98% -3326.67% 0.01x 1.03x $-74.96 Million
2019 -67.00% -361.10% 0.17x 1.11x $-114.47 Million
2020 0.00% -351.87% 0.31x 0.00x $-162.65 Million
2021 -7.24% -51.80% 0.11x 1.28x $-77.18 Million
2022 -51.86% -229.90% 0.18x 1.28x $-201.26 Million
2023 -60.76% -202.88% 0.22x 1.38x $-155.71 Million
2024 -42.94% -88.34% 0.32x 1.52x $-89.38 Million

Industry Comparison

This section compares Butterfly Network Inc's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $694,749,556
  • Average return on equity (ROE) among peers: -25.46%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Butterfly Network Inc (BFLY) $203.83 Million -20.98% 0.42x $767.91 Million
Advanced Biomedical Technologies Inc (ABMT) $-4.46 Million 0.00% 0.00x $14.18K
Abbott Laboratories (ABT) $4.82 Billion 39.04% 1.31x $191.37 Billion
Acarix AB (publ) (ACIXF) $1.93 Million -127.02% 0.21x $26.42 Million
Adagio Medical Holdings, Inc Common Stock (ADGM) $-72.62 Million 0.00% 0.00x $4.05 Million
Adm Tronics Unltd (ADMT) $-12.69K 0.00% 0.00x $3.17 Million
Aethlon Medical Inc (AEMD) $-3.07 Million 0.00% 0.00x $2.79 Million
Acutus Medical Inc (AFIB) $126.58 Million -80.56% 0.52x $732.88K
Adapthealth Corp (AHCO) $2.07 Billion 7.56% 1.54x $914.25 Million
Allied Healthcare Products Inc. (AHPIQ) $8.88 Million -33.95% 1.22x $726.24
20/20 Biolabs, Inc. Common Stock (AIDX) $3.39 Million -59.65% 0.38x $9.18 Million